Priorities and Challenges in Methodology for Human Health Risk Assessment from Combined Exposure to Multiple Chemicals

Abstract

This paper reviews key elements in the assessment of human health effects from combined exposure to multiple chemicals taking into consideration current knowledge and challenges to identify areas where scientific advancement is mostly needed and proposes a decision-making scheme on the basis of existing methods and tools. The assumption of dose addition and estimation of the hazard index (HI) is considered as a starting point in component-based risk assessments. When, based on the generic HI approach, an unacceptable risk is identified, more specific risk assessment options may be implemented sequentially or in parallel depending on problem formulation, characteristics of the chemical group under assessment, exposure levels, data availability and resources. For prospective risk assessments, the reference point index/margin of exposure (RPI/MOET) (Option 1) or modified RPI/normalized MOET (mRPI/nMOET) (Option 2) approaches may be implemented focusing on the specific mixture effect. Relative potency factors (RPFs) may also be used in the RPI approach since a common uncertainty factor for each mixture component is introduced in the assessment. Increased specificity in the risk assessment may also be achieved when exposure of selected population groups is considered (Option 3/exposure). For retrospective risk assessments, human biomonitoring data available for vulnerable population groups (Option 3/susceptibility) may present more focused scenarios for consideration in human health risk management decisions. In data-poor situations, the option of using the mixture assessment factor (MAF) is proposed (Option 4), where an additional uncertainty factor is applied on each mixture component prior to estimating the HI. The magnitude of the MAF may be determined by the number of mixture components, their individual potencies and their proportions in the mixture, as previously reported. It is acknowledged that implementation of currently available methods and tools for human health risk assessment from combined exposure to multiple chemicals by risk assessors will be enhanced by ongoing scientific developments on new approach methodologies (NAMs), integrated approaches to testing and assessment (IATA), uncertainty analysis tools, data sharing platforms, risk assessment software as well as guideline development to meet legislative requirements.

Reaction-Based Multisignal Detection of Palladium with High Sensitivity, Selectivity, and Reliability

“…In the same time, researchers tried to develop Pd-free catalysts for coupling reactions, but later found that the reagents were contaminated by trace palladium . In addition, palladium species bind to various biomolecules such as proteins and nucleic acids, leading to a range of physiological dysfunctions and negatively affecting human health. , Thus, the development of simple and reliable sensors to monitor palladium with extremely high sensitivity and selectivity is required.…”

Boosting knowledge and harmonisation in the mycotoxin field through sustainable scientific alliances – MYCOBOOST

“…31 1. Uptake of computational methods in mycotoxins risk assessment New Approach Methods (NAMs) in risk assessment (Magurany et al, 2023;Nikolopoulou et al, 2023) encompass a range of novel and alternative approaches utilised for evaluating the safety and potential risks posed by chemicals, drugs, or other substances. These methods, often based on in vitro and in silico techniques, aim to provide robust and predictive data, while minimising or eliminating the reliance on animal testing.…”